A study investigating the correlation between interleukin-6 (IL-6) plasma levels and treatment outcomes of selective serotonin reuptake inhibitors in patients with major depressive disorder
Latest Information Update: 01 Sep 2021
At a glance
- Drugs Paroxetine (Primary)
- Indications Major depressive disorder
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 01 Sep 2021 New trial record